CORVITOL

This brand name is authorized in Albania, Lithuania

Active ingredients

The drug CORVITOL contains one active pharmaceutical ingredient (API):

1 Metoprolol
UNII W5S57Y3A5L - METOPROLOL TARTRATE

Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation.

Read about Metoprolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C07AB02 Metoprolol C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AL Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor Identifier(s): 352/16, 353/16
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1000517, 1014175, 1014176

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈